ED
CRNC icon

Exane Derivatives’s Cerence CRNC Stock Holding History

Exane Derivatives’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$782 Sell
31
-1,519
-98% -$45.4K ﹤0.01% 528
2022
Q1 		$56K Sell
1,550
-229
-13% -$11.3K 0.02% 557
2021
Q4 		$136K Sell
1,779
-502
-22% -$44.3K 0.03% 406
2021
Q3 		$219K Sell
2,281
-441
-16% -$48.1K 0.05% 376
2021
Q2 		$308K Buy
2,722
+123
+5% +$12.1K 0.07% 283
2021
Q1 		$233K Buy
+2,599
New +$286K 0.07% 277

Other funds holding CRNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Exane Derivatives's CRNC Position: Q2 2022 in Review

Exane Derivatives reduced its Cerence (CRNC) stake by 98% in Q2 2022, selling an estimated $45.4K and leaving 31 shares worth $782. The position accounts for ﹤0.01% of the portfolio, ranked #528.

Exane Derivatives first reported a position in CRNC in Q1 2021 and has held it in 6 quarters since. The position peaked at $308K in Q2 2021. 269 funds tracked by Wall St. Rank hold CRNC as of Q2 2022.

  • Exane Derivatives held 31 shares of Cerence worth $782 as of Q2 2022.
  • Exane Derivatives sold 1,519 Cerence shares in Q2 2022, an estimated $45.4K.
  • Cerence made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #528 holding.
  • Exane Derivatives first reported a position in Cerence in Q1 2021 and has held it in 6 quarters since.
  • Exane Derivatives's Cerence position peaked at $308K in Q2 2021.
  • 269 funds tracked by Wall St. Rank held Cerence as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.